APO Research
Talk to an analyst

APO RESEARCH · REPORT

Blood Biological Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Blood Biological Products Market Outlook and Growth Opportunities 2026

2 January 2026206 pages

Choose your research edition.

Industry ResearchBlood Biological Products Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Biological Products Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Blood Biological Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Biological Products Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Biological Products Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Blood Biological Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Blood Biological Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Blood Biological Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Blood Biological Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Blood Biological Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Blood Biological Products market include Yuanda Shuyang, Takeda, Weiguang Bio, Nanyue Bio, Hualan Bio, Shuanglin Bio, Tiantan Bio, RAAS and Octapharma, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Blood Biological Products market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Blood Biological Products and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Biological Products revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Biological Products market.

Blood Biological Products Segment by Company

Yuanda Shuyang

Takeda

Weiguang Bio

Nanyue Bio

Hualan Bio

Shuanglin Bio

Tiantan Bio

RAAS

Octapharma

LFB Group

KM Biologics

Kedrion

Grifols

CSL

CBPO

BPL

Boya Bio

Biotest

Blood Biological Products Segment by Type

Albumin

Immune Globulin

Coagulation Factor

Other

Blood Biological Products Segment by Application

Immunology

Hematology

Other

Blood Biological Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Blood Biological Products status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blood Biological Products key companies, revenue, market share, and recent developments.

3. To split the Blood Biological Products breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blood Biological Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Biological Products significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Biological Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Biological Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Biological Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Biological Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Biological Products industry.

Chapter 3: Detailed analysis of Blood Biological Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blood Biological Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blood Biological Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Biological Products Industry Trends Table 2. Blood Biological Products Industry Drivers Table 3. Blood Biological Products Industry Opportunities and Challenges Table 4. Blood Biological Products Industry Restraints Table 5. Global Blood Biological Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Biological Products Revenue Share by Company (2021-2026) Table 7. Global Blood Biological Products Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blood Biological Products Key Company Manufacturing Base & Headquarters Table 9. Global Blood Biological Products Company, Product Type & Application Table 10. Global Blood Biological Products Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blood Biological Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Albumin Table 15. Significant Companies of Immune Globulin Table 16. Significant Companies of Coagulation Factor Table 17. Significant Companies of Other Table 18. Global Blood Biological Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Blood Biological Products Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Blood Biological Products Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Blood Biological Products Sales Value Share by Type (2021-2026) Table 22. Global Blood Biological Products Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Immunology Table 24. Significant Companies of Hematology Table 25. Significant Companies of Other Table 26. Global Blood Biological Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Blood Biological Products Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Blood Biological Products Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Blood Biological Products Sales Value Share by Application (2021-2026) Table 30. Global Blood Biological Products Sales Value Share by Application (2027-2032) Table 31. Global Blood Biological Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Blood Biological Products Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Blood Biological Products Sales Value Share by Region (2021-2026) Table 34. Global Blood Biological Products Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Blood Biological Products Sales Value Share by Region (2027-2032) Table 36. Global Blood Biological Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Blood Biological Products Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Blood Biological Products Sales Value Market Share by Country (2021-2026) Table 39. Global Blood Biological Products Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Blood Biological Products Sales Value Market Share by Country (2027-2032) Table 41. Yuanda Shuyang Company Information Table 42. Yuanda Shuyang Business Overview Table 43. Yuanda Shuyang Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Yuanda Shuyang Blood Biological Products Product Portfolio Table 45. Yuanda Shuyang Recent Development Table 46. Takeda Company Information Table 47. Takeda Business Overview Table 48. Takeda Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Takeda Blood Biological Products Product Portfolio Table 50. Takeda Recent Development Table 51. Weiguang Bio Company Information Table 52. Weiguang Bio Business Overview Table 53. Weiguang Bio Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Weiguang Bio Blood Biological Products Product Portfolio Table 55. Weiguang Bio Recent Development Table 56. Nanyue Bio Company Information Table 57. Nanyue Bio Business Overview Table 58. Nanyue Bio Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Nanyue Bio Blood Biological Products Product Portfolio Table 60. Nanyue Bio Recent Development Table 61. Hualan Bio Company Information Table 62. Hualan Bio Business Overview Table 63. Hualan Bio Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Hualan Bio Blood Biological Products Product Portfolio Table 65. Hualan Bio Recent Development Table 66. Shuanglin Bio Company Information Table 67. Shuanglin Bio Business Overview Table 68. Shuanglin Bio Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Shuanglin Bio Blood Biological Products Product Portfolio Table 70. Shuanglin Bio Recent Development Table 71. Tiantan Bio Company Information Table 72. Tiantan Bio Business Overview Table 73. Tiantan Bio Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Tiantan Bio Blood Biological Products Product Portfolio Table 75. Tiantan Bio Recent Development Table 76. RAAS Company Information Table 77. RAAS Business Overview Table 78. RAAS Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. RAAS Blood Biological Products Product Portfolio Table 80. RAAS Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Octapharma Blood Biological Products Product Portfolio Table 85. Octapharma Recent Development Table 86. LFB Group Company Information Table 87. LFB Group Business Overview Table 88. LFB Group Blood Biological Products Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. LFB Group Blood Biological Products Product Portfolio Table 90. LFB Group Recent Development Table 91. KM Biologics Company Information Table 92. KM Biologics Business Overview Table 93. KM Biologics Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. KM Biologics Blood Biological Products Product Portfolio Table 95. KM Biologics Recent Development Table 96. Kedrion Company Information Table 97. Kedrion Business Overview Table 98. Kedrion Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Kedrion Blood Biological Products Product Portfolio Table 100. Kedrion Recent Development Table 101. Grifols Company Information Table 102. Grifols Business Overview Table 103. Grifols Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Grifols Blood Biological Products Product Portfolio Table 105. Grifols Recent Development Table 106. CSL Company Information Table 107. CSL Business Overview Table 108. CSL Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. CSL Blood Biological Products Product Portfolio Table 110. CSL Recent Development Table 111. CBPO Company Information Table 112. CBPO Business Overview Table 113. CBPO Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. CBPO Blood Biological Products Product Portfolio Table 115. CBPO Recent Development Table 116. BPL Company Information Table 117. BPL Business Overview Table 118. BPL Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. BPL Blood Biological Products Product Portfolio Table 120. BPL Recent Development Table 121. Boya Bio Company Information Table 122. Boya Bio Business Overview Table 123. Boya Bio Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Boya Bio Blood Biological Products Product Portfolio Table 125. Boya Bio Recent Development Table 126. Biotest Company Information Table 127. Biotest Business Overview Table 128. Biotest Blood Biological Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Biotest Blood Biological Products Product Portfolio Table 130. Biotest Recent Development Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Blood Biological Products Product Image Figure 2. Global Blood Biological Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Biological Products Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Biological Products Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Albumin Image Figure 8. Immune Globulin Image Figure 9. Coagulation Factor Image Figure 10. Other Image Figure 11. Global Blood Biological Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Blood Biological Products Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Blood Biological Products Sales Value Share by Type (2021-2032) Figure 14. Immunology Image Figure 15. Hematology Image Figure 16. Other Image Figure 17. Global Blood Biological Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Blood Biological Products Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Blood Biological Products Sales Value Share by Application (2021-2032) Figure 20. Global Blood Biological Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Blood Biological Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Blood Biological Products Sales Value (2021-2032) & (US$ Million) Figure 23. North America Blood Biological Products Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Blood Biological Products Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Blood Biological Products Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Blood Biological Products Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Blood Biological Products Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Blood Biological Products Sales Value (2021-2032) & (US$ Million) Figure 29. South America Blood Biological Products Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Blood Biological Products Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Blood Biological Products Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Blood Biological Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Blood Biological Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Blood Biological Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Albumin
  • Immune Globulin
  • Coagulation Factor
  • Other
Applications
  • Immunology
  • Hematology
  • Other
Companies covered
  • Yuanda Shuyang
  • Takeda
  • Weiguang Bio
  • Nanyue Bio
  • Hualan Bio
  • Shuanglin Bio
  • Tiantan Bio
  • RAAS
  • Octapharma
  • LFB Group
  • KM Biologics
  • Kedrion
  • Grifols
  • CSL
  • CBPO
  • BPL
  • Boya Bio
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Biological Products Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Biological Products Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blood Biological Products Market Dynamics
  1. 2.1 Blood Biological Products Industry Trends
  2. 2.2 Blood Biological Products Industry Drivers
  3. 2.3 Blood Biological Products Industry Opportunities and Challenges
  4. 2.4 Blood Biological Products Industry Restraints
3 Blood Biological Products Market by Company
  1. 3.1 Global Blood Biological Products Company Revenue Ranking in 2025
  2. 3.2 Global Blood Biological Products Revenue by Company (2021-2026)
  3. 3.3 Global Blood Biological Products Company Ranking (2024-2026)
  4. 3.4 Global Blood Biological Products Company Manufacturing Base and Headquarters
  5. 3.5 Global Blood Biological Products Company Product Type and Application
  6. 3.6 Global Blood Biological Products Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blood Biological Products Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blood Biological Products Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blood Biological Products Market by Type
  1. 4.1 Blood Biological Products Type Introduction
  2. 4.1.1 Albumin
  3. 4.1.2 Immune Globulin
  4. 4.1.3 Coagulation Factor
  5. 4.1.4 Other
  6. 4.2 Global Blood Biological Products Sales Value by Type
  7. 4.2.1 Global Blood Biological Products Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Blood Biological Products Sales Value by Type (2021-2032)
  9. 4.2.3 Global Blood Biological Products Sales Value Share by Type (2021-2032)
5 Blood Biological Products Market by Application
  1. 5.1 Blood Biological Products Application Introduction
  2. 5.1.1 Immunology
  3. 5.1.2 Hematology
  4. 5.1.3 Other
  5. 5.2 Global Blood Biological Products Sales Value by Application
  6. 5.2.1 Global Blood Biological Products Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Biological Products Sales Value by Application (2021-2032)
  8. 5.2.3 Global Blood Biological Products Sales Value Share by Application (2021-2032)
6 Blood Biological Products Regional Value Analysis
  1. 6.1 Global Blood Biological Products Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Biological Products Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blood Biological Products Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blood Biological Products Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Biological Products Sales Value (2021-2032)
  7. 6.3.2 North America Blood Biological Products Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blood Biological Products Sales Value (2021-2032)
  10. 6.4.2 Europe Blood Biological Products Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blood Biological Products Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blood Biological Products Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blood Biological Products Sales Value (2021-2032)
  16. 6.6.2 South America Blood Biological Products Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blood Biological Products Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blood Biological Products Sales Value Share by Country, 2025 VS 2032
7 Blood Biological Products Country-level Value Analysis
  1. 7.1 Global Blood Biological Products Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Biological Products Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blood Biological Products Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blood Biological Products Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blood Biological Products Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blood Biological Products Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blood Biological Products Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blood Biological Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blood Biological Products Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blood Biological Products Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blood Biological Products Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blood Biological Products Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blood Biological Products Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blood Biological Products Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blood Biological Products Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blood Biological Products Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blood Biological Products Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blood Biological Products Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blood Biological Products Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blood Biological Products Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blood Biological Products Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blood Biological Products Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blood Biological Products Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blood Biological Products Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blood Biological Products Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blood Biological Products Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blood Biological Products Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blood Biological Products Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blood Biological Products Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blood Biological Products Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blood Biological Products Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blood Biological Products Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blood Biological Products Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blood Biological Products Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blood Biological Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuanda Shuyang
  2. 8.1.1 Yuanda Shuyang Company Information
  3. 8.1.2 Yuanda Shuyang Business Overview
  4. 8.1.3 Yuanda Shuyang Blood Biological Products Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yuanda Shuyang Blood Biological Products Product Portfolio
  6. 8.1.5 Yuanda Shuyang Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Blood Biological Products Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Blood Biological Products Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Weiguang Bio
  14. 8.3.1 Weiguang Bio Company Information
  15. 8.3.2 Weiguang Bio Business Overview
  16. 8.3.3 Weiguang Bio Blood Biological Products Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Weiguang Bio Blood Biological Products Product Portfolio
  18. 8.3.5 Weiguang Bio Recent Developments
  19. 8.4 Nanyue Bio
  20. 8.4.1 Nanyue Bio Company Information
  21. 8.4.2 Nanyue Bio Business Overview
  22. 8.4.3 Nanyue Bio Blood Biological Products Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Nanyue Bio Blood Biological Products Product Portfolio
  24. 8.4.5 Nanyue Bio Recent Developments
  25. 8.5 Hualan Bio
  26. 8.5.1 Hualan Bio Company Information
  27. 8.5.2 Hualan Bio Business Overview
  28. 8.5.3 Hualan Bio Blood Biological Products Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Bio Blood Biological Products Product Portfolio
  30. 8.5.5 Hualan Bio Recent Developments
  31. 8.6 Shuanglin Bio
  32. 8.6.1 Shuanglin Bio Company Information
  33. 8.6.2 Shuanglin Bio Business Overview
  34. 8.6.3 Shuanglin Bio Blood Biological Products Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shuanglin Bio Blood Biological Products Product Portfolio
  36. 8.6.5 Shuanglin Bio Recent Developments
  37. 8.7 Tiantan Bio
  38. 8.7.1 Tiantan Bio Company Information
  39. 8.7.2 Tiantan Bio Business Overview
  40. 8.7.3 Tiantan Bio Blood Biological Products Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tiantan Bio Blood Biological Products Product Portfolio
  42. 8.7.5 Tiantan Bio Recent Developments
  43. 8.8 RAAS
  44. 8.8.1 RAAS Company Information
  45. 8.8.2 RAAS Business Overview
  46. 8.8.3 RAAS Blood Biological Products Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RAAS Blood Biological Products Product Portfolio
  48. 8.8.5 RAAS Recent Developments
  49. 8.9 Octapharma
  50. 8.9.1 Octapharma Company Information
  51. 8.9.2 Octapharma Business Overview
  52. 8.9.3 Octapharma Blood Biological Products Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Octapharma Blood Biological Products Product Portfolio
  54. 8.9.5 Octapharma Recent Developments
  55. 8.10 LFB Group
  56. 8.10.1 LFB Group Company Information
  57. 8.10.2 LFB Group Business Overview
  58. 8.10.3 LFB Group Blood Biological Products Revenue and Gross Margin (2021-2026)
  59. 8.10.4 LFB Group Blood Biological Products Product Portfolio
  60. 8.10.5 LFB Group Recent Developments
  61. 8.11 KM Biologics
  62. 8.11.1 KM Biologics Company Information
  63. 8.11.2 KM Biologics Business Overview
  64. 8.11.3 KM Biologics Blood Biological Products Revenue and Gross Margin (2021-2026)
  65. 8.11.4 KM Biologics Blood Biological Products Product Portfolio
  66. 8.11.5 KM Biologics Recent Developments
  67. 8.12 Kedrion
  68. 8.12.1 Kedrion Company Information
  69. 8.12.2 Kedrion Business Overview
  70. 8.12.3 Kedrion Blood Biological Products Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kedrion Blood Biological Products Product Portfolio
  72. 8.12.5 Kedrion Recent Developments
  73. 8.13 Grifols
  74. 8.13.1 Grifols Company Information
  75. 8.13.2 Grifols Business Overview
  76. 8.13.3 Grifols Blood Biological Products Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Grifols Blood Biological Products Product Portfolio
  78. 8.13.5 Grifols Recent Developments
  79. 8.14 CSL
  80. 8.14.1 CSL Company Information
  81. 8.14.2 CSL Business Overview
  82. 8.14.3 CSL Blood Biological Products Revenue and Gross Margin (2021-2026)
  83. 8.14.4 CSL Blood Biological Products Product Portfolio
  84. 8.14.5 CSL Recent Developments
  85. 8.15 CBPO
  86. 8.15.1 CBPO Company Information
  87. 8.15.2 CBPO Business Overview
  88. 8.15.3 CBPO Blood Biological Products Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CBPO Blood Biological Products Product Portfolio
  90. 8.15.5 CBPO Recent Developments
  91. 8.16 BPL
  92. 8.16.1 BPL Company Information
  93. 8.16.2 BPL Business Overview
  94. 8.16.3 BPL Blood Biological Products Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BPL Blood Biological Products Product Portfolio
  96. 8.16.5 BPL Recent Developments
  97. 8.17 Boya Bio
  98. 8.17.1 Boya Bio Company Information
  99. 8.17.2 Boya Bio Business Overview
  100. 8.17.3 Boya Bio Blood Biological Products Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Boya Bio Blood Biological Products Product Portfolio
  102. 8.17.5 Boya Bio Recent Developments
  103. 8.18 Biotest
  104. 8.18.1 Biotest Company Information
  105. 8.18.2 Biotest Business Overview
  106. 8.18.3 Biotest Blood Biological Products Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Biotest Blood Biological Products Product Portfolio
  108. 8.18.5 Biotest Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst